Enact Holdings Inc. ACT

Key data

The business

Enact sells private mortgage insurance. When an American buys a home with less than 20% down, Fannie Mae and Freddie Mac require insurance on the loan; Enact writes that policy, collects a small premium every month, and pays the lender if the borrower defaults and the foreclosure sells short. It is one product, one segment, sold to a few hundred lenders. The moat is threefold: a large in-force book of policies that keep paying premiums for years after they are written, GSE capital rules that keep new entrants scarce, and $5.4 billion of capital standing behind the promise. The scar tissue is that this is the business that nearly killed its parent, Genworth, after 2008, when the industry wrote into a bubble and paid claims for a decade. Genworth still owns a controlling stake and is selling that stake down quarter by quarter.

The numbers

The top line barely moves; the earnings line is the whole story.

Revenue grew about 4% across the year while EPS rose 13% and net income only 4%, to $174.8M. The gap is the share count, down about 7% as stock was retired. Q2 beat the lone Street estimate on operating earnings. This is not a growth business; it is a stable-profit business shrinking its own shares.

Net income has sat flat for three years, $665M, $688M, $674M, yet EPS rose every year, because the share count keeps falling. That is the engine: about 13% return on equity, almost none reinvested for growth, nearly all handed back. Enact repurchased $382M of stock in 2025 and $93M more last quarter, and pays a dividend on top. Consensus sees $4.80 this year and $5.03 next, roughly 6% growth, which is the buyback doing the work. The variant view: the market pays a top-of-range multiple for a flat-earnings, capital-return name, and both Genworth's selling and any turn in claims are what would close that gap. The print that settles it is the quarterly loss trend.

A combined ratio in the mid-30s means Enact keeps about 65 cents of every premium dollar as underwriting profit, before investment income even arrives. The number to watch is the loss ratio, up several points in a year as claims normalize off pandemic-era lows. Persistency stayed high, holding premiums earned roughly flat while investment income of $73M carried the revenue gain.

Management

Insiders sold $185M over twelve months and bought nothing, but every dollar is Genworth, the parent, selling down its controlling stake, not operating managers heading for the exit; plan status is not disclosed on the Form 4s. That selling is a structural overhang, not a verdict on the business, and Enact's buyback partly exists to absorb it. Capital allocation is the thing to judge, and it is disciplined: $382M of buybacks in 2025 plus a growing dividend, funded from earnings, with debt flat near $745M. CEO Rohit Gupta has run this book through the whole rate cycle without a reserve scare.

How it fails or surprises you

A housing downturn. A recession that lifts unemployment and cracks home prices is the one thing that breaks this. The loss ratio is already drifting up off historic lows; after 2008, mortgage insurers ran loss ratios above 100% for years. A move toward 40% would roughly halve earnings, faster than any buyback could offset. The print: the quarterly delinquency rate and new-default notices.

The Genworth overhang clears (right tail). Genworth sells roughly $30M a quarter. The day that stake is block-sold or drops below control, the constant seller disappears and the top-of-range multiple can re-rate toward the 1.9x its peers fetch. The market pays nothing for this today because the overhang is visible every quarter. The print: a Genworth secondary or a stake below 50%.

Losses stay benign and buybacks compound (the read could be wrong). My "flat-earnings" framing understates the case if the loss ratio simply holds near today's low-teens through a soft landing. Then 13% ROE, almost entirely returned at 1.2x book, compounds book value per share while the count shrinks 7% a year, a low-teens total return with no multiple help. The print: loss ratio holding under 20% as buybacks continue.

Closing thoughts

The market already prices most of this story: the benign loss ratio, the heavy buyback, and Genworth's steady selling are all disclosed, which is why the stock sits at a low-double-digit earnings multiple and below the 1.9x its peers fetch. The edge, if there is one, sits on Genworth's overhang clearing faster than expected, which would land in a single secondary or 13D filing, or on the loss ratio staying lower longer than the market assumes, which you watch quarter by quarter in the delinquency data. The fatter tail is up, because the downside is a housing recession you can watch build in the credit data and exit, while the upside, a cleared overhang, could land in one filing. What is genuinely at risk is the loss ratio: a real credit turn would take earnings down faster than buybacks lift them.

The bet is still that American homeowners keep paying their mortgages, so Enact keeps almost all of every premium dollar and hands it back. What breaks it is a jump in defaults, and the pair to watch is the loss ratio against the buyback pace: as long as the first stays in the low teens and the second keeps shrinking the share count, the machine compounds per share. If the loss ratio doubles before the housing cycle turns, the buyback cannot outrun it.